Immune checkpoint modulation enhances HIV-1 antibody induction
Todd Bradley(Children's Mercy Hospital), Barton F. Haynes(Duke University), David C. Montefiori(Duke University), Masayuki Kuraoka(Duke University), Richard M. Scearce(Duke University), Laurent Verkoczy(Duke University), Sampa Santra(Beth Israel Deaconess Medical Center), Ane Ogbe(University of Oxford), Xuejun Chen(National Institutes of Health), Cindy Bowman(Duke University), Persephone Borrow(Jenner Institute), Rafi Ahmed(Emory University), Chen‐Hao Yeh(Duke University), Ali H. Ellebedy(Washington University in St. Louis), Laura L. Sutherland(Duke University), Maggie Barr, Frederick W. Alt(Boston Children's Hospital), Mark G. Lewis(Bioqual), Derek W. Cain(Duke University), Mattia Bonsignori(National Institute of Allergy and Infectious Diseases), Kevin Wiehe(Duke University), Garnett Kelsoe(Duke University), Ming Tian(Boston Children's Hospital), John R. Mascola(National Institute of Allergy and Infectious Diseases), Kevin O. Saunders(Duke University), Hilary Bouton-Verville(Duke University), Robert Parks(Duke University), Huan Chen(Beth Israel Deaconess Medical Center), Cheng Cheng(Chinese Academy of Medical Sciences & Peking Union Medical College), M. Anthony Moody(Duke University)
Cited by 38
Related Papers
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
|Science|1984|3.6k
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
|Nature Immunology|2020|1.4k